Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin

Uncertainty regarding an optimal antiplatelet regimen still exists in patients with breakthrough acute ischemic stroke (AIS) while on aspirin. This study provides an analysis of a prospective multicenter registry between April 2008 and April 2014. Eligible patients were on aspirin at the time of AIS...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Kim, Joon-Tae, Kim, Beom Joon, Park, Jong-Moo, Lee, Soo Joo, Cha, Jae-Kwan, Park, Tai Hwan, Lee, Kyung Bok, Lee, Jun, Hong, Keun-Sik, Lee, Byung-Chul, Kim, Dong-Eog, Choi, Jay Chol, Kwon, Jee-Hyun, Shin, Dong-Ick, Sohn, Sung Il, Lee, Ji Sung, Lee, Juneyoung, Bae, Hee-Joon
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541489/
https://ncbi.nlm.nih.gov/pubmed/33028887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-73836-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi